scholarly journals A Kernel-based Nonlinear Manifold Learning for EEG Channel Selection with Application to Alzheimer's Disease

2021 ◽  
Author(s):  
Shenal Rajintha Gunawardena ◽  
Ptolemaios G Sarrigiannis ◽  
Daniel J Blackburn ◽  
Fei He
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Manifold Learning ◽  
Latent Variable ◽  
Channel Selection ◽  
Dynamical Analysis ◽  
Support Vector ◽  
Variable Model ◽  
Eeg Data ◽  
Spatio Temporal

This paper introduces a novel EEG channel selection method to determine which channel interrelationships provide the best classification accuracy between a group of patients with Alzheimer's disease (AD) and a cohort of age matched healthy controls (HC). Thereby, determine which inter-relationships are more important for the in-depth dynamical analysis to further understand how neurodegenerative diseases such as AD affects global and local brain dynamics. The channel selection methodology uses kernel-based nonlinear manifold learning via Isomap and Gaussian Process Latent Variable Model (Isomap-GPLVM). The Isomap-GPLVM method is employed to learn both the spatial and temporal local similarities and global dissimilarities present within the EEG data structures. The resulting kernel (dis)similarity matrix is used as a measure of synchrony between EEG channels. Based on this information, channel-specific linear Support Vector Machine (SVM) classification is then used to determine which spatio-temporal channel inter-relationships are more important for in-depth dynamical analysis. In this work, the analysis of EEG data from HC and AD patients is presented as a case study. Our analysis shows that inter-relationships between channels in the fronto-parietal region and the rest are better at differentiating between AD and HC groups.

scholarly journals Nonlinear Classification of EEG recordings from patients with Alzheimer’s Disease using Gaussian Process Latent Variable Model

2020 ◽  
Author(s):  
S. Rajintha. A. S. Gunawardena ◽  
Fei He ◽  
Ptolemaios Sarrigiannis ◽  
Daniel J. Blackburn
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Gaussian Process ◽  
Manifold Learning ◽  
Latent Variable ◽  
Time Window ◽  
Support Vector ◽  
Nonlinear Dimensionality Reduction ◽  
Variable Model

AbstractIn this work, nonlinear temporal features from multi-channel EEGs are used for the classification of Alzheimer’s disease patients from healthy individuals. This was achieved by temporal manifold learning using Gaussian Process Latent Variable Models (GPLVM) as a nonlinear dimensionality reduction technique. Classification of the extracted features was undertaken using a nonlinear Support Vector Machine. Comparisons were made against the linear counterpart, Principle Component Analysis while exploring the effect of the time window or EEG epoch length used. It was demonstrated that temporal manifold learning using GPLVM is better in extracting features that attain high separability and prediction accuracy. This work aims to set the significance of using GPLVM temporal manifold learning for EEG feature extraction in the classification of Alzheimer’s disease.

A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer's Disease in Clinical Trials

2018 ◽  
Vol 15 (5) ◽  
pp. 429-442 ◽  
Author(s):  
Nishant Verma ◽  
S. Natasha Beretvas ◽  
Belen Pascual ◽  
Joseph C. Masdeu ◽  
Mia K. Markey ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trials ◽  
Cognitive Impairment ◽  
Latent Variable ◽  
Brain Regions ◽  
Disease Assessment ◽  
Latent Variable Analysis ◽  
The Relationship ◽  
Selection Of

Background: Combining optimized cognitive (Alzheimer's Disease Assessment Scale- Cognitive subscale, ADAS-Cog) and atrophy markers of Alzheimer's disease for tracking progression in clinical trials may provide greater sensitivity than currently used methods, which have yielded negative results in multiple recent trials. Furthermore, it is critical to clarify the relationship among the subcomponents yielded by cognitive and imaging testing, to address the symptomatic and anatomical variability of Alzheimer's disease. Method: Using latent variable analysis, we thoroughly investigated the relationship between cognitive impairment, as assessed on the ADAS-Cog, and cerebral atrophy. A biomarker was developed for Alzheimer's clinical trials that combines cognitive and atrophy markers. Results: Atrophy within specific brain regions was found to be closely related with impairment in cognitive domains of memory, language, and praxis. The proposed biomarker showed significantly better sensitivity in tracking progression of cognitive impairment than the ADAS-Cog in simulated trials and a real world problem. The biomarker also improved the selection of MCI patients (78.8±4.9% specificity at 80% sensitivity) that will evolve to Alzheimer's disease for clinical trials. Conclusion: The proposed biomarker provides a boost to the efficacy of clinical trials focused in the mild cognitive impairment (MCI) stage by significantly improving the sensitivity to detect treatment effects and improving the selection of MCI patients that will evolve to Alzheimer’s disease.

P4-225: Analysis of Spatio-Temporal Features of Histopathology in Murine Alzheimer's Disease Models and Human Alzheimer's Disease Samples

2016 ◽  
Vol 12 ◽  
pp. P1115-P1115
Author(s):  
Vera Niederkofler ◽  
Christina Hoeller ◽  
Joerg Neddens ◽  
Ewald Auer ◽  
Heinrich Roemer ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Disease Models ◽  
Temporal Features ◽  
Spatio Temporal

A Comparative Study of Alzheimer Detection Techniques

2021 ◽  
Vol 9 (8) ◽  
pp. 2877-2883
Author(s):  
Adwait Patil
Keyword(s):  
Machine Learning ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Comparative Study ◽  
Fuzzy System ◽  
Early Stage ◽  
Machine Learning Algorithms ◽  
Support Vector ◽  
Detection Techniques

Abstract: Alzheimer’s disease is one of the neurodegenerative disorders. It initially starts with innocuous symptoms but gradually becomes severe. This disease is so dangerous because there is no treatment, the disease is detected but typically at a later stage. So it is important to detect Alzheimer at an early stage to counter the disease and for a probable recovery for the patient. There are various approaches currently used to detect symptoms of Alzheimer’s disease (AD) at an early stage. The fuzzy system approach is not widely used as it heavily depends on expert knowledge but is quite efficient in detecting AD as it provides a mathematical foundation for interpreting the human cognitive processes. Another more accurate and widely accepted approach is the machine learning detection of AD stages which uses machine learning algorithms like Support Vector Machines (SVMs) , Decision Tree , Random Forests to detect the stage depending on the data provided. The final approach is the Deep Learning approach using multi-modal data that combines image , genetic data and patient data using deep models and then uses the concatenated data to detect the AD stage more efficiently; this method is obscure as it requires huge volumes of data. This paper elaborates on all the three approaches and provides a comparative study about them and which method is more efficient for AD detection. Keywords: Alzheimer’s Disease (AD), Fuzzy System , Machine Learning , Deep Learning , Multimodal data

scholarly journals To Explore the Predictive Power of Visuomotor Network Dysfunctions in Mild Cognitive Impairment and Alzheimer’s Disease

2021 ◽  
Vol 15 ◽  
Author(s):  
Justine Staal ◽  
Francesco Mattace-Raso ◽  
Hennie A. M. Daniels ◽  
Johannes van der Steen ◽  
Johan J. M. Pel
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Support Vector Machine ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Predictive Power ◽  
Area Under The Curve ◽  
Classification Performance ◽  
Support Vector ◽  
Potential Biomarker

BackgroundResearch into Alzheimer’s disease has shifted toward the identification of minimally invasive and less time-consuming modalities to define preclinical stages of Alzheimer’s disease.MethodHere, we propose visuomotor network dysfunctions as a potential biomarker in AD and its prodromal stage, mild cognitive impairment with underlying the Alzheimer’s disease pathology. The functionality of this network was tested in terms of timing, accuracy, and speed with goal-directed eye-hand tasks. The predictive power was determined by comparing the classification performance of a zero-rule algorithm (baseline), a decision tree, a support vector machine, and a neural network using functional parameters to classify controls without cognitive disorders, mild cognitive impaired patients, and Alzheimer’s disease patients.ResultsFair to good classification was achieved between controls and patients, controls and mild cognitive impaired patients, and between controls and Alzheimer’s disease patients with the support vector machine (77–82% accuracy, 57–93% sensitivity, 63–90% specificity, 0.74–0.78 area under the curve). Classification between mild cognitive impaired patients and Alzheimer’s disease patients was poor, as no algorithm outperformed the baseline (63% accuracy, 0% sensitivity, 100% specificity, 0.50 area under the curve).Comparison with Existing Method(s)The classification performance found in the present study is comparable to that of the existing CSF and MRI biomarkers.ConclusionThe data suggest that visuomotor network dysfunctions have potential in biomarker research and the proposed eye-hand tasks could add to existing tests to form a clear definition of the preclinical phenotype of AD.

scholarly journals Applying 3DPCANet and Functional Magnetic Resonance Imaging to Aided Diagnosis of Alzheimer’s Disease

2021 ◽  
Author(s):  
Yu Wang ◽  
Hongfei Jia ◽  
Yifan Duan ◽  
Hongbing Xiao
Keyword(s):  
Magnetic Resonance Imaging ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Magnetic Resonance ◽  
Functional Magnetic Resonance Imaging ◽  
Brain Regions ◽  
Support Vector ◽  
Functional Magnetic Resonance ◽  
Resonance Imaging ◽  
Public Data

Abstract Alzheimer's disease (AD) is a progressive neurodegenerative disease, which changes the structure of brain regions by some hidden causes. In this paper for assisting doctors to make correct judgments, an improved 3DPCANet method is proposed to classify AD by combining the mean (mALFF) of the whole brain. The main idea includes that firstly, the functional magnetic resonance imaging (fMRI) data is pre-processed, and mALFF is calculated to get the corresponding matrix. Then the features of mALFF images are extracted via the improved 3DPCANet network. Finally, AD patients with different stages are classified using support vector machine (SVM). Experiments results based on public data from the Alzheimer’s disease neuroimaging initiative (ADNI) show that the proposed approach has better performance compared with state-of-the-art methods. The accuracies of AD vs. significant memory concern (SMC), SMC vs. late mild cognitive impairment (LMCI), and normal control (NC) vs. SMC reach respectively 92.42%, 91.80%, and 89.50%, which testifies the feasibility and effectiveness of the proposed method.

Sign in / Sign up

Export Citation Format

Share Document